{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:37:46Z","timestamp":1789677466131,"version":"4.0.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,4]]},"DOI":"10.7759\/cureus.35756","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T15:06:42Z","timestamp":1677942402000},"source":"Crossref","is-referenced-by-count":18,"title":["The Sigma Enigma: A Narrative Review of Sigma Receptors"],"prefix":"10.7759","author":[{"given":"Joseph","family":"Pergolizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Breve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana K","family":"Christo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Christo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.12.5391","article-title":"A brief history of opiates, opioid peptides, and opioid receptors","volume":"90","author":"Brownstein MJ","year":"1993","unstructured":"Brownstein MJ. A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci U S A. 1993, 90:5391-3. 10.1073\/pnas.90.12.5391","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human \u03c31 receptor","volume":"532","author":"Schmidt HR","year":"2016","unstructured":"Schmidt HR, Zheng S, Gurpinar E, Koehl A, Manglik A, Kruse AC. Crystal structure of the human \u03c31 receptor. Nature. 2016, 532:527-30. 10.1038\/nature17391","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning, and expression of the mammalian sigma1-binding site","volume":"93","author":"Hanner M","year":"1996","unstructured":"Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A. 1996, 93:8072-7. 10.1073\/pnas.93.15.8072","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","article-title":"Structural determinants of sigma receptor affinity","volume":"32","author":"Largent BL","year":"1987","unstructured":"Largent BL, Wikstr\u00f6m H, Gundlach AL, Snyder SH. Structural determinants of sigma receptor affinity. Mol Pharmacol. 1987, 32:772-84.","journal-title":"Mol Pharmacol"},{"key":"ref5","article-title":"Sigma receptors: biology and function","volume":"42","author":"Walker JM","year":"1990","unstructured":"Walker JM, Bowen WD, Walker FO, Matsumoto RR, De Costa B, Rice KC. Sigma receptors: biology and function. Pharmacol Rev. 1990, 42:355-402.","journal-title":"Pharmacol Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01186","article-title":"The sigma-1 receptor: when adaptive regulation of cell electrical activity contributes to stimulant addiction and cancer","volume":"13","author":"Soriani O","year":"2019","unstructured":"Soriani O, Kourrich S. The sigma-1 receptor: when adaptive regulation of cell electrical activity contributes to stimulant addiction and cancer. Front Neurosci. 2019, 13:1186. 10.3389\/fnins.2019.01186","journal-title":"Front Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"Hayashi T","year":"2007","unstructured":"Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell. 2007, 131:596-610. 10.1016\/j.cell.2007.08.036","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2019.07.006","article-title":"The molecular function of \u03c3 receptors: past, present, and future","volume":"40","author":"Schmidt HR","year":"2019","unstructured":"Schmidt HR, Kruse AC. The molecular function of \u03c3 receptors: past, present, and future. Trends Pharmacol Sci. 2019, 40:636-54. 10.1016\/j.tips.2019.07.006","journal-title":"Trends Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1126\/science.2832949","article-title":"Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems","volume":"240","author":"Su TP","year":"1988","unstructured":"Su TP, London ED, Jaffe JH. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science. 1988, 240:219-21. 10.1126\/science.2832949","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-50174-1_2","article-title":"Structural perspectives on sigma-1 receptor function","volume":"964","author":"Alon A","year":"2017","unstructured":"Alon A, Schmidt H, Zheng S, Kruse AC. Structural perspectives on sigma-1 receptor function. Adv Exp Med Biol. 2017, 964:5-13. 10.1007\/978-3-319-50174-1_2","journal-title":"Adv Exp Med Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00419","article-title":"Molecular interplay between the sigma-1 receptor, steroids, and ion channels","volume":"10","author":"Morales-L\u00e1zaro SL","year":"2019","unstructured":"Morales-L\u00e1zaro SL, Gonz\u00e1lez-Ram\u00edrez R, Rosenbaum T. Molecular interplay between the sigma-1 receptor, steroids, and ion channels. Front Pharmacol. 2019, 10:419. 10.3389\/fphar.2019.00419","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2010.08.007","article-title":"The sigma-1 receptor chaperone as an inter-organelle signaling modulator","volume":"31","author":"Su TP","year":"2010","unstructured":"Su TP, Hayashi T, Maurice T, Buch S, Ruoho AE. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol Sci. 2010, 31:557-66. 10.1016\/j.tips.2010.08.007","journal-title":"Trends Pharmacol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1124\/mol.115.101170","article-title":"Biochemical pharmacology of the sigma-1 receptor","volume":"89","author":"Chu UB","year":"2016","unstructured":"Chu UB, Ruoho AE. Biochemical pharmacology of the sigma-1 receptor. Mol Pharmacol. 2016, 89:142-53. 10.1124\/mol.115.101170","journal-title":"Mol Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-009-0308-8","article-title":"Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter","volume":"116","author":"Cozzi NV","year":"2009","unstructured":"Cozzi NV, Gopalakrishnan A, Anderson LL, Feih JT, Shulgin AT, Daley PF, Ruoho AE. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J Neural Transm (Vienna). 2009, 116:1591-9. 10.1007\/s00702-009-0308-8","journal-title":"J Neural Transm (Vienna)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.12.051","article-title":"Choline is an intracellular messenger linking extracellular stimuli to IP(3)-evoked Ca(2+) signals through sigma-1 receptors","volume":"26","author":"Brailoiu E","year":"2019","unstructured":"Brailoiu E, Chakraborty S, Brailoiu GC, et al.. Choline is an intracellular messenger linking extracellular stimuli to IP(3)-evoked Ca(2+) signals through sigma-1 receptors. Cell Rep. 2019, 26:330-337.e4. 10.1016\/j.celrep.2018.12.051","journal-title":"Cell Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/10799893.2015.1015737","article-title":"Sigma receptors [\u03c3Rs]: biology in normal and diseased states","volume":"36","author":"Rousseaux CG","year":"2016","unstructured":"Rousseaux CG, Greene SF. Sigma receptors [\u03c3Rs]: biology in normal and diseased states. J Recept Signal Transduct Res. 2016, 36:327-88. 10.3109\/10799893.2015.1015737","journal-title":"J Recept Signal Transduct Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.051284","article-title":"Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export","volume":"306","author":"Hayashi T","year":"2003","unstructured":"Hayashi T, Su TP. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther. 2003, 306:718-25. 10.1124\/jpet.103.051284","journal-title":"J Pharmacol Exp Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.03019","article-title":"The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function","volume":"119","author":"Appenzeller-Herzog C","year":"2006","unstructured":"Appenzeller-Herzog C, Hauri HP. The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function. J Cell Sci. 2006, 119:2173-83. 10.1242\/jcs.03019","journal-title":"J Cell Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/350153a0","article-title":"Action potentials must admit calcium to evoke transmitter release","volume":"350","author":"Mulkey RM","year":"1991","unstructured":"Mulkey RM, Zucker RS. Action potentials must admit calcium to evoke transmitter release. Nature. 1991, 350:153-5. 10.1038\/350153a0","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2174\/1871524910909030184","article-title":"Sigma-1 receptor chaperones and diseases","volume":"9","author":"Tsai SY","year":"2009","unstructured":"Tsai SY, Hayashi T, Mori T, Su TP. Sigma-1 receptor chaperones and diseases. Cent Nerv Syst Agents Med Chem. 2009, 9:184-9. 10.2174\/1871524910909030184","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.15.1.799","article-title":"The translocon: a dynamic gateway at the ER membrane","volume":"15","author":"Johnson AE","year":"1999","unstructured":"Johnson AE, van Waes MA. The translocon: a dynamic gateway at the ER membrane. Annu Rev Cell Dev Biol. 1999, 15:799-842. 10.1146\/annurev.cellbio.15.1.799","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007526","article-title":"Protein folding and quality control in the ER","volume":"3","author":"Araki K","year":"2011","unstructured":"Araki K, Nagata K. Protein folding and quality control in the ER. Cold Spring Harb Perspect Biol. 2011, 3:a007526. 10.1101\/cshperspect.a007526","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz C","year":"2012","unstructured":"Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012, 13:89-102. 10.1038\/nrm3270","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.genom.7.080505.115737","article-title":"Protein misfolding and human disease","volume":"7","author":"Gregersen N","year":"2006","unstructured":"Gregersen N, Bross P, Vang S, Christensen JH. Protein misfolding and human disease. Annu Rev Genomics Hum Genet. 2006, 7:103-24. 10.1146\/annurev.genom.7.080505.115737","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(03)00116-8","article-title":"Mitochondria: releasing power for life and unleashing the machineries of death","volume":"112","author":"Newmeyer DD","year":"2003","unstructured":"Newmeyer DD, Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell. 2003, 112:481-90. 10.1016\/s0092-8674(03)00116-8","journal-title":"Cell"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201511036","article-title":"Metabolic regulation of mitochondrial dynamics","volume":"212","author":"Mishra P","year":"2016","unstructured":"Mishra P, Chan DC. Metabolic regulation of mitochondrial dynamics. J Cell Biol. 2016, 212:379-87. 10.1083\/jcb.201511036","journal-title":"J Cell Biol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-017-0380-6","article-title":"Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases","volume":"24","author":"Weng TY","year":"2017","unstructured":"Weng TY, Tsai SA, Su TP. Roles of sigma-1 receptors on mitochondrial functions relevant to neurodegenerative diseases. J Biomed Sci. 2017, 24:74. 10.1186\/s12929-017-0380-6","journal-title":"J Biomed Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0210-7","article-title":"The cell biology of mitochondrial membrane dynamics","volume":"21","author":"Giacomello M","year":"2020","unstructured":"Giacomello M, Pyakurel A, Glytsou C, Scorrano L. The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol. 2020, 21:204-24. 10.1038\/s41580-020-0210-7","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.09.022","article-title":"Sigma receptors as potential therapeutic targets for neuroprotection","volume":"743","author":"Nguyen L","year":"2014","unstructured":"Nguyen L, Kaushal N, Robson MJ, Matsumoto RR. Sigma receptors as potential therapeutic targets for neuroprotection. Eur J Pharmacol. 2014, 743:42-7. 10.1016\/j.ejphar.2014.09.022","journal-title":"Eur J Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2019.07.003","article-title":"Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling","volume":"49","author":"Wu Y","year":"2019","unstructured":"Wu Y, Chen M, Jiang J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion. 2019, 49:35-45. 10.1016\/j.mito.2019.07.003","journal-title":"Mitochondrion"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2021.1939681","article-title":"The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer's","volume":"25","author":"Prasanth MI","year":"2021","unstructured":"Prasanth MI, Malar DS, Tencomnao T, Brimson JM. The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer's. Expert Opin Ther Targets. 2021, 25:401-14. 10.1080\/14728222.2021.1939681","journal-title":"Expert Opin Ther Targets"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry VH","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol. 2010, 6:193-201. 10.1038\/nrneurol.2010.17","journal-title":"Nat Rev Neurol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1159\/000328989","article-title":"The yin and yang of microglia","volume":"33","author":"Czeh M","year":"2011","unstructured":"Czeh M, Gressens P, Kaindl AM. The yin and yang of microglia. Dev Neurosci. 2011, 33:199-209. 10.1159\/000328989","journal-title":"Dev Neurosci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2013.04.009","article-title":"SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation","volume":"247","author":"Robson MJ","year":"2013","unstructured":"Robson MJ, Turner RC, Naser ZJ, McCurdy CR, Huber JD, Matsumoto RR. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Exp Neurol. 2013, 247:134-42. 10.1016\/j.expneurol.2013.04.009","journal-title":"Exp Neurol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5700-7","article-title":"Sigma-2 receptor\/TMEM97 agonist PB221 as an alternative drug for brain tumor","volume":"19","author":"Liu CC","year":"2019","unstructured":"Liu CC, Yu CF, Wang SC, et al.. Sigma-2 receptor\/TMEM97 agonist PB221 as an alternative drug for brain tumor. BMC Cancer. 2019, 19:473. 10.1186\/s12885-019-5700-7","journal-title":"BMC Cancer"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27051682","article-title":"New pharmacological strategies against pancreatic adenocarcinoma: the multifunctional thiosemicarbazone FA4","volume":"27","author":"Anobile DP","year":"2022","unstructured":"Anobile DP, Niso M, Puerta A, et al.. New pharmacological strategies against pancreatic adenocarcinoma: the multifunctional thiosemicarbazone FA4. Molecules. 2022, 27:3-7. 10.3390\/molecules27051682","journal-title":"Molecules"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice T","year":"2009","unstructured":"Maurice T, Su TP. The pharmacology of sigma-1 receptors. Pharmacol Ther. 2009, 124:195-206. 10.1016\/j.pharmthera.2009.07.001","journal-title":"Pharmacol Ther"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddw204","article-title":"Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells","volume":"25","author":"Ebrahimi-Fakhari D","year":"2016","unstructured":"Ebrahimi-Fakhari D, Wahlster L, Bartz F, et al.. Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells. Hum Mol Genet. 2016, 25:3588-99. 10.1093\/hmg\/ddw204","journal-title":"Hum Mol Genet"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041505","article-title":"Lipids and Alzheimer's disease","volume":"21","author":"Kao YC","year":"2020","unstructured":"Kao YC, Ho PC, Tu YK, Jou IM, Tsai KJ. Lipids and Alzheimer's disease. Int J Mol Sci. 2020, 21:3-7. 10.3390\/ijms21041505","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2020.01.009","article-title":"Lipid rafts: controversies resolved, mysteries remain","volume":"30","author":"Levental I","year":"2020","unstructured":"Levental I, Levental KR, Heberle FA. Lipid rafts: controversies resolved, mysteries remain. Trends Cell Biol. 2020, 30:341-53. 10.1016\/j.tcb.2020.01.009","journal-title":"Trends Cell Biol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/syn.20041","article-title":"Sigma-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution","volume":"53","author":"Takebayashi M","year":"2004","unstructured":"Takebayashi M, Hayashi T, Su TP. Sigma-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution. Synapse. 2004, 53:90-103. 10.1002\/syn.20041","journal-title":"Synapse"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1177\/0883073814539561","article-title":"Mitochondrial genetics and disease","volume":"29","author":"Area-Gomez E","year":"2014","unstructured":"Area-Gomez E, Schon EA. Mitochondrial genetics and disease. J Child Neurol. 2014, 29:1208-15. 10.1177\/0883073814539561","journal-title":"J Child Neurol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.0c00851","article-title":"The origin of lipid rafts","volume":"59","author":"Regen SL","year":"2020","unstructured":"Regen SL. The origin of lipid rafts. Biochemistry. 2020, 59:4617-21. 10.1021\/acs.biochem.0c00851","journal-title":"Biochemistry"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7827(85)90011-6","article-title":"Lipids of nervous tissue: composition and metabolism","volume":"24","author":"Sastry PS","year":"1985","unstructured":"Sastry PS. Lipids of nervous tissue: composition and metabolism. Prog Lipid Res. 1985, 24:69-176. 10.1016\/0163-7827(85)90011-6","journal-title":"Prog Lipid Res"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25225439","article-title":"Sigma-2 receptor-a potential target for cancer\/Alzheimer's disease treatment via its regulation of cholesterol homeostasis","volume":"25","author":"Yang K","year":"2020","unstructured":"Yang K, Zeng C, Wang C, Sun M, Yin D, Sun T. Sigma-2 receptor-a potential target for cancer\/Alzheimer's disease treatment via its regulation of cholesterol homeostasis. Molecules. 2020, 25:3-7. 10.3390\/molecules25225439","journal-title":"Molecules"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.132","article-title":"Cholesterol metabolism in Huntington disease","volume":"7","author":"Karasinska JM","year":"2011","unstructured":"Karasinska JM, Hayden MR. Cholesterol metabolism in Huntington disease. Nat Rev Neurol. 2011, 7:561-72. 10.1038\/nrneurol.2011.132","journal-title":"Nat Rev Neurol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2017.03.003","article-title":"Apolipoprotein E, receptors, and modulation of Alzheimer's disease","volume":"83","author":"Zhao N","year":"2018","unstructured":"Zhao N, Liu CC, Qiao W, Bu G. Apolipoprotein E, receptors, and modulation of Alzheimer's disease. Biol Psychiatry. 2018, 83:347-57. 10.1016\/j.biopsych.2017.03.003","journal-title":"Biol Psychiatry"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-021-00933-4","article-title":"Apolipoprotein E and atherosclerosis","volume":"23","author":"Marais AD","year":"2021","unstructured":"Marais AD. Apolipoprotein E and atherosclerosis. Curr Atheroscler Rep. 2021, 23:34. 10.1007\/s11883-021-00933-4","journal-title":"Curr Atheroscler Rep"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105215","article-title":"Cholesterol homeostasis: researching a dialogue between the brain and peripheral tissues","volume":"163","author":"Gliozzi M","year":"2021","unstructured":"Gliozzi M, Musolino V, Bosco F, et al.. Cholesterol homeostasis: researching a dialogue between the brain and peripheral tissues. Pharmacol Res. 2021, 163:105215. 10.1016\/j.phrs.2020.105215","journal-title":"Pharmacol Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-2052-6","article-title":"The endoplasmic reticulum: structure, function and response to cellular signaling","volume":"73","author":"Schwarz DS","year":"2016","unstructured":"Schwarz DS, Blower MD. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci. 2016, 73:79-94. 10.1007\/s00018-015-2052-6","journal-title":"Cell Mol Life Sci"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.99","article-title":"ER stress and the unfolded protein response in neurodegeneration","volume":"13","author":"Hetz C","year":"2017","unstructured":"Hetz C, Saxena S. ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol. 2017, 13:477-91. 10.1038\/nrneurol.2017.99","journal-title":"Nat Rev Neurol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.199307","article-title":"From the unfolded protein response to metabolic diseases - lipids under the spotlight","volume":"131","author":"Ho N","year":"2018","unstructured":"Ho N, Xu C, Thibault G. From the unfolded protein response to metabolic diseases - lipids under the spotlight. J Cell Sci. 2018, 131:jcs199307. 10.1242\/jcs.199307","journal-title":"J Cell Sci"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701079","article-title":"High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase","volume":"121","author":"Moebius FF","year":"1997","unstructured":"Moebius FF, Reiter RJ, Hanner M, Glossmann H. High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase. Br J Pharmacol. 1997, 121:1-6. 10.1038\/sj.bjp.0701079","journal-title":"Br J Pharmacol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00714","article-title":"The sigma-2 receptor selective agonist siramesine (Lu 28-179) decreases cocaine-reinforced pavlovian learning and alters glutamatergic and dopaminergic input to the striatum","volume":"8","author":"Klawonn AM","year":"2017","unstructured":"Klawonn AM, Nilsson A, R\u00e5dberg CF, et al.. The sigma-2 receptor selective agonist siramesine (Lu 28-179) decreases cocaine-reinforced pavlovian learning and alters glutamatergic and dopaminergic input to the striatum. Front Pharmacol. 2017, 8:714. 10.3389\/fphar.2017.00714","journal-title":"Front Pharmacol"},{"key":"ref55","doi-asserted-by":"crossref","DOI":"10.2310\/7290.2011.00009","article-title":"Characterization and evaluation of two novel fluorescent sigma-2 receptor ligands as proliferation probes","volume":"10","author":"Zeng C","year":"2011","unstructured":"Zeng C, Vangveravong S, Jones LA, et al.. Characterization and evaluation of two novel fluorescent sigma-2 receptor ligands as proliferation probes. Mol Imaging. 2011, 10:420-33.","journal-title":"Mol Imaging"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071877","article-title":"The biological function of sigma-2 receptor\/TMEM97 and its utility in pet imaging studies in cancer","volume":"12","author":"Zeng C","year":"2020","unstructured":"Zeng C, Riad A, Mach RH. The biological function of sigma-2 receptor\/TMEM97 and its utility in pet imaging studies in cancer. Cancers (Basel). 2020, 12:3-7. 10.3390\/cancers12071877","journal-title":"Cancers (Basel)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/med.21297","article-title":"Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy","volume":"34","author":"Huang YS","year":"2014","unstructured":"Huang YS, Lu HL, Zhang LJ, Wu Z. Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy. Med Res Rev. 2014, 34:532-66. 10.1002\/med.21297","journal-title":"Med Res Rev"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.12.004","article-title":"Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine","volume":"152","author":"Kourrich S","year":"2013","unstructured":"Kourrich S, Hayashi T, Chuang JY, Tsai SY, Su TP, Bonci A. Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell. 2013, 152:236-47. 10.1016\/j.cell.2012.12.004","journal-title":"Cell"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.04.016","article-title":"Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies","volume":"49","author":"Nguyen EC","year":"2005","unstructured":"Nguyen EC, McCracken KA, Liu Y, Pouw B, Matsumoto RR. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology. 2005, 49:638-45. 10.1016\/j.neuropharm.2005.04.016","journal-title":"Neuropharmacology"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/s0028-3908(02)00056-4","article-title":"Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides","volume":"42","author":"Matsumoto RR","year":"2002","unstructured":"Matsumoto RR, McCracken KA, Pouw B, Zhang Y, Bowen WD. Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides. Neuropharmacology. 2002, 42:1043-55. 10.1016\/s0028-3908(02)00056-4","journal-title":"Neuropharmacology"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-09-03572.2003","article-title":"Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward","volume":"23","author":"Romieu P","year":"2003","unstructured":"Romieu P, Martin-Fardon R, Bowen WD, Maurice T. Sigma 1 receptor-related neuroactive steroids modulate cocaine-induced reward. J Neurosci. 2003, 23:3572-6. 10.1523\/JNEUROSCI.23-09-03572.2003","journal-title":"J Neurosci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-7634(02)00017-9","article-title":"Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity","volume":"26","author":"Maurice T","year":"2002","unstructured":"Maurice T, Martin-Fardon R, Romieu P, Matsumoto RR. Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci Biobehav Rev. 2002, 26:499-527. 10.1016\/s0149-7634(02)00017-9","journal-title":"Neurosci Biobehav Rev"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/164_2016_97","article-title":"Sigma receptors and alcohol use disorders","volume":"244","author":"Sabino V","year":"2017","unstructured":"Sabino V, Cottone P. Sigma receptors and alcohol use disorders. Handb Exp Pharmacol. 2017, 244:219-36. 10.1007\/164_2016_97","journal-title":"Handb Exp Pharmacol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00687","article-title":"Role of sigma receptors in alcohol addiction","volume":"10","author":"Quadir SG","year":"2019","unstructured":"Quadir SG, Cottone P, Sabino V. Role of sigma receptors in alcohol addiction. Front Pharmacol. 2019, 10:687. 10.3389\/fphar.2019.00687","journal-title":"Front Pharmacol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1906592116","article-title":"Proteostasis collapse is a driver of cell aging and death","volume":"116","author":"Santra M","year":"2019","unstructured":"Santra M, Dill KA, de Graff AM. Proteostasis collapse is a driver of cell aging and death. Proc Natl Acad Sci U S A. 2019, 116:22173-8. 10.1073\/pnas.1906592116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(93)91441-t","article-title":"Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss","volume":"623","author":"Jansen KL","year":"1993","unstructured":"Jansen KL, Faull RL, Storey P, Leslie RA. Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer's disease correlates with CA1 pyramidal cell loss. Brain Res. 1993, 623:299-302. 10.1016\/0006-8993(93)91441-t","journal-title":"Brain Res"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-007-0094-z","article-title":"Low density of sigma1 receptors in early Alzheimer's disease","volume":"22","author":"Mishina M","year":"2008","unstructured":"Mishina M, Ohyama M, Ishii K, et al.. Low density of sigma1 receptors in early Alzheimer's disease. Ann Nucl Med. 2008, 22:151-6. 10.1007\/s12149-007-0094-z","journal-title":"Ann Nucl Med"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10347","article-title":"Amyloid beta-protein affects cholesterol metabolism in cultured neurons: implications for pivotal role of cholesterol in the amyloid cascade","volume":"70","author":"Gong JS","year":"2002","unstructured":"Gong JS, Sawamura N, Zou K, Sakai J, Yanagisawa K, Michikawa M. Amyloid beta-protein affects cholesterol metabolism in cultured neurons: implications for pivotal role of cholesterol in the amyloid cascade. J Neurosci Res. 2002, 70:438-46. 10.1002\/jnr.10347","journal-title":"J Neurosci Res"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210535","article-title":"Elevated cellular cholesterol in familial Alzheimer's presenilin 1 mutation is associated with lipid raft localization of \u03b2-amyloid precursor protein","volume":"14","author":"Cho YY","year":"2019","unstructured":"Cho YY, Kwon OH, Park MK, Kim TW, Chung S. Elevated cellular cholesterol in familial Alzheimer's presenilin 1 mutation is associated with lipid raft localization of \u03b2-amyloid precursor protein. PLoS One. 2019, 14:e0210535. 10.1371\/journal.pone.0210535","journal-title":"PLoS One"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24248-8","article-title":"Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis","volume":"8","author":"Chu CS","year":"2018","unstructured":"Chu CS, Tseng PT, Stubbs B, et al.. Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis. Sci Rep. 2018, 8:5804. 10.1038\/s41598-018-24248-8","journal-title":"Sci Rep"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000070182.02537.84","article-title":"Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology","volume":"61","author":"Pappolla MA","year":"2003","unstructured":"Pappolla MA, Bryant-Thomas TK, Herbert D, et al.. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology. 2003, 61:199-205. 10.1212\/01.wnl.0000070182.02537.84","journal-title":"Neurology"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1159\/000503105","article-title":"Association between use of statin and risk of dementia: A meta-analysis of observational studies","volume":"54","author":"Poly TN","year":"2020","unstructured":"Poly TN, Islam MM, Walther BA, Yang HC, Wu CC, Lin MC, Li YC. Association between use of statin and risk of dementia: A meta-analysis of observational studies. Neuroepidemiology. 2020, 54:214-26. 10.1159\/000503105","journal-title":"Neuroepidemiology"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2015.05.008","article-title":"Lipidomics of human brain aging and Alzheimer's disease pathology","volume":"122","author":"Naud\u00ed A","year":"2015","unstructured":"Naud\u00ed A, Cabr\u00e9 R, Jov\u00e9 M, et al.. Lipidomics of human brain aging and Alzheimer's disease pathology. Int Rev Neurobiol. 2015, 122:133-89. 10.1016\/bs.irn.2015.05.008","journal-title":"Int Rev Neurobiol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000080","article-title":"Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study","volume":"82","author":"Pottala JV","year":"2014","unstructured":"Pottala JV, Yaffe K, Robinson JG, Espeland MA, Wallace R, Harris WS. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology. 2014, 82:435-42. 10.1212\/WNL.0000000000000080","journal-title":"Neurology"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2018-0072","article-title":"Sigma-2 receptor: past, present and perspectives on multiple therapeutic exploitations","volume":"10","author":"Abate C","year":"2018","unstructured":"Abate C, Niso M, Berardi F. Sigma-2 receptor: past, present and perspectives on multiple therapeutic exploitations. Future Med Chem. 2018, 10:1997-2018. 10.4155\/fmc-2018-0072","journal-title":"Future Med Chem"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2022.0412","article-title":"Amyloid cascade hypothesis for the treatment of Alzheimer's disease progress and challenges","volume":"13","author":"Wu T","year":"2022","unstructured":"Wu T, Lin D, Cheng Y, et al.. Amyloid cascade hypothesis for the treatment of Alzheimer's disease progress and challenges. Aging Dis. 2022, 13:1745-58. 10.14336\/AD.2022.0412","journal-title":"Aging Dis"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113168","article-title":"Overview of therapeutic targets in management of dementia","volume":"152","author":"Malik R","year":"2022","unstructured":"Malik R, Kalra S, Bhatia S, et al.. Overview of therapeutic targets in management of dementia. Biomed Pharmacother. 2022, 152:113168. 10.1016\/j.biopha.2022.113168","journal-title":"Biomed Pharmacother"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(90)90186-a","article-title":"N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors","volume":"179","author":"Monnet FP","year":"1990","unstructured":"Monnet FP, Debonnel G, Junien JL, De Montigny C. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol. 1990, 179:441-5. 10.1016\/0014-2999(90)90186-a","journal-title":"Eur J Pharmacol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132049","article-title":"The impact of mitochondrial dysfunction in amyotrophic lateral sclerosis","volume":"11","author":"Zhao J","year":"2022","unstructured":"Zhao J, Wang X, Huo Z, et al.. The impact of mitochondrial dysfunction in amyotrophic lateral sclerosis. Cells. 2022, 11:3-7. 10.3390\/cells11132049","journal-title":"Cells"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2014.12.012","article-title":"The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis","volume":"127","author":"Fukunaga K","year":"2015","unstructured":"Fukunaga K, Shinoda Y, Tagashira H. The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis. J Pharmacol Sci. 2015, 127:36-41. 10.1016\/j.jphs.2014.12.012","journal-title":"J Pharmacol Sci"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.015012","article-title":"Wildtype \u03c31 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity","volume":"295","author":"Shinoda Y","year":"2020","unstructured":"Shinoda Y, Haga Y, Akagawa K, Fukunaga K. Wildtype \u03c31 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity. J Biol Chem. 2020, 295:17573-87. 10.1074\/jbc.RA120.015012","journal-title":"J Biol Chem"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22534","article-title":"A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis","volume":"70","author":"Al-Saif A","year":"2011","unstructured":"Al-Saif A, Al-Mohanna F, Bohlega S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol. 2011, 70:913-9. 10.1002\/ana.22534","journal-title":"Ann Neurol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.11.011","article-title":"p53 represses the mevalonate pathway to mediate tumor suppression","volume":"176","author":"Moon SH","year":"2019","unstructured":"Moon SH, Huang CH, Houlihan SL, et al.. p53 represses the mevalonate pathway to mediate tumor suppression. Cell. 2019, 176:564-580.e19. 10.1016\/j.cell.2018.11.011","journal-title":"Cell"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.247","article-title":"Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia","volume":"36","author":"Gallagher EJ","year":"2017","unstructured":"Gallagher EJ, Zelenko Z, Neel BA, Antoniou IM, Rajan L, Kase N, LeRoith D. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia. Oncogene. 2017, 36:6462-71. 10.1038\/onc.2017.247","journal-title":"Oncogene"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.602","article-title":"Sigma-2 ligands induce tumour cell death by multiple signalling pathways","volume":"106","author":"Zeng C","year":"2012","unstructured":"Zeng C, Rothfuss J, Zhang J, et al.. Sigma-2 ligands induce tumour cell death by multiple signalling pathways. Br J Cancer. 2012, 106:693-701. 10.1038\/bjc.2011.602","journal-title":"Br J Cancer"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbior.2014.10.003","article-title":"Lipid rafts as major platforms for signaling regulation in cancer","volume":"57","author":"Mollinedo F","year":"2015","unstructured":"Mollinedo F, Gajate C. Lipid rafts as major platforms for signaling regulation in cancer. Adv Biol Regul. 2015, 57:130-46. 10.1016\/j.jbior.2014.10.003","journal-title":"Adv Biol Regul"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1771","article-title":"Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines","volume":"67","author":"Palmer CP","year":"2007","unstructured":"Palmer CP, Mahen R, Schnell E, Djamgoz MB, Aydar E. Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines. Cancer Res. 2007, 67:11166-75. 10.1158\/0008-5472.CAN-07-1771","journal-title":"Cancer Res"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0122","article-title":"Molecular pathways: sterols and receptor signaling in cancer","volume":"20","author":"Gabitova L","year":"2014","unstructured":"Gabitova L, Gorin A, Astsaturov I. Molecular pathways: sterols and receptor signaling in cancer. Clin Cancer Res. 2014, 20:28-34. 10.1158\/1078-0432.CCR-13-0122","journal-title":"Clin Cancer Res"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26123743","article-title":"\u03c32 Receptor and its role in cancer with focus on a multitarget directed ligand (MTDL) approach","volume":"26","author":"Abatematteo FS","year":"2021","unstructured":"Abatematteo FS, Niso M, Lacivita E, Abate C. \u03c32 Receptor and its role in cancer with focus on a multitarget directed ligand (MTDL) approach. Molecules. 2021, 26:1-5. 10.3390\/molecules26123743","journal-title":"Molecules"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04942-2","article-title":"Cell death regulation by MAMs: from molecular mechanisms to therapeutic implications in cardiovascular diseases","volume":"13","author":"Li YE","year":"2022","unstructured":"Li YE, Sowers JR, Hetz C, Ren J. Cell death regulation by MAMs: from molecular mechanisms to therapeutic implications in cardiovascular diseases. Cell Death Dis. 2022, 13:504. 10.1038\/s41419-022-04942-2","journal-title":"Cell Death Dis"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1715972115","article-title":"TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain","volume":"115","author":"Ort\u00edz-Renter\u00eda M","year":"2018","unstructured":"Ort\u00edz-Renter\u00eda M, Ju\u00e1rez-Contreras R, Gonz\u00e1lez-Ram\u00edrez R, et al.. TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain. Proc Natl Acad Sci U S A. 2018, 115:E1657-66. 10.1073\/pnas.1715972115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.4155\/ppa-2020-0007","article-title":"Sigma-1 receptor antagonists: promising players in fighting neuropathic pain","volume":"9","author":"Linciano P","year":"2020","unstructured":"Linciano P, Rossino G, Listro R, Rossi D, Collina S. Sigma-1 receptor antagonists: promising players in fighting neuropathic pain. Pharm Pat Anal. 2020, 9:77-85. 10.4155\/ppa-2020-0007","journal-title":"Pharm Pat Anal"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.08.006","article-title":"Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice","volume":"13","author":"Nieto FR","year":"2012","unstructured":"Nieto FR, Cend\u00e1n CM, S\u00e1nchez-Fern\u00e1ndez C, et al.. Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice. J Pain. 2012, 13:1107-21. 10.1016\/j.jpain.2012.08.006","journal-title":"J Pain"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.232459","article-title":"Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy","volume":"13","author":"Bruna J","year":"2018","unstructured":"Bruna J, Velasco R. Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy. Neural Regen Res. 2018, 13:775-8. 10.4103\/1673-5374.232459","journal-title":"Neural Regen Res"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-022-01545-3","article-title":"Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists","volume":"27","author":"Khani E","year":"2022","unstructured":"Khani E, Entezari-Maleki T. Fluvoxamine and long COVID-19; a new role for sigma-1 receptor (S1R) agonists. Mol Psychiatry. 2022, 27:3562. 10.1038\/s41380-022-01545-3","journal-title":"Mol Psychiatry"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10111514","article-title":"Highly specific sigma receptor ligands exhibit anti-viral properties in SARS-CoV-2 infected cells","volume":"10","author":"Ostrov DA","year":"2021","unstructured":"Ostrov DA, Bluhm AP, Li D, et al.. Highly specific sigma receptor ligands exhibit anti-viral properties in SARS-CoV-2 infected cells. Pathogens. 2021, 10:3-7. 10.3390\/pathogens10111514","journal-title":"Pathogens"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1586\/ern.09.40","article-title":"Sigma-1 receptors in major depression and anxiety","volume":"9","author":"Kulkarni SK","year":"2009","unstructured":"Kulkarni SK, Dhir A. Sigma-1 receptors in major depression and anxiety. Expert Rev Neurother. 2009, 9:1021-34. 10.1586\/ern.09.40","journal-title":"Expert Rev Neurother"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00468","article-title":"Blockade of the sigma-1 receptor relieves cognitive and emotional impairments associated to chronic osteoarthritis pain","volume":"10","author":"Carcol\u00e9 M","year":"2019","unstructured":"Carcol\u00e9 M, Zamanillo D, Merlos M, Fern\u00e1ndez-Pastor B, Caba\u00f1ero D, Maldonado R. Blockade of the sigma-1 receptor relieves cognitive and emotional impairments associated to chronic osteoarthritis pain. Front Pharmacol. 2019, 10:468. 10.3389\/fphar.2019.00468","journal-title":"Front Pharmacol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1097\/HRP.0000000000000198","article-title":"Pain and depression: a systematic review","volume":"26","author":"IsHak WW","year":"2018","unstructured":"IsHak WW, Wen RY, Naghdechi L, et al.. Pain and depression: a systematic review. Harv Rev Psychiatry. 2018, 26:352-63. 10.1097\/HRP.0000000000000198","journal-title":"Harv Rev Psychiatry"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.2174\/187152709789824633","article-title":"Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?","volume":"8","author":"Hashimoto K","year":"2009","unstructured":"Hashimoto K. Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia?. CNS Neurol Disord Drug Targets. 2009, 8:470-4. 10.2174\/187152709789824633","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-020-0157-5","article-title":"Sigma-1 receptor activity in primary sensory neurons is a critical driver of neuropathic pain","volume":"29","author":"Shin SM","year":"2022","unstructured":"Shin SM, Wang F, Qiu C, Itson-Zoske B, Hogan QH, Yu H. Sigma-1 receptor activity in primary sensory neurons is a critical driver of neuropathic pain. Gene Ther. 2022, 29:1-15. 10.1038\/s41434-020-0157-5","journal-title":"Gene Ther"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2017-0117","article-title":"Role of sigma 1 receptor in high fat diet-induced peripheral neuropathy","volume":"398","author":"Song T","year":"2017","unstructured":"Song T, Zhao J, Ma X, Zhang Z, Jiang B, Yang Y. Role of sigma 1 receptor in high fat diet-induced peripheral neuropathy. Biol Chem. 2017, 398:1141-9. 10.1515\/hsz-2017-0117","journal-title":"Biol Chem"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.897","article-title":"Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in rats","volume":"21","author":"Paniagua N","year":"2017","unstructured":"Paniagua N, Gir\u00f3n R, Goicoechea C, L\u00f3pez-Miranda V, Vela JM, Merlos M, Mart\u00edn Fontelles MI. Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in rats. Eur J Pain. 2017, 21:61-72. 10.1002\/ejp.897","journal-title":"Eur J Pain"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-50174-1_20","article-title":"The role of sigma 1 receptor as a neuroprotective target in glaucoma","volume":"964","author":"Mysona B","year":"2017","unstructured":"Mysona B, Kansara N, Zhao J, Bollinger K. The role of sigma 1 receptor as a neuroprotective target in glaucoma. Adv Exp Med Biol. 2017, 964:299-307. 10.1007\/978-3-319-50174-1_20","journal-title":"Adv Exp Med Biol"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-50174-1_10","article-title":"Sigma-1 receptors and neurodegenerative diseases: towards a hypothesis of sigma-1 receptors as amplifiers of neurodegeneration and neuroprotection","volume":"964","author":"Nguyen L","year":"2017","unstructured":"Nguyen L, Lucke-Wold BP, Mookerjee S, Kaushal N, Matsumoto RR. Sigma-1 receptors and neurodegenerative diseases: towards a hypothesis of sigma-1 receptors as amplifiers of neurodegeneration and neuroprotection. Adv Exp Med Biol. 2017, 964:133-52. 10.1007\/978-3-319-50174-1_10","journal-title":"Adv Exp Med Biol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(97)01064-9","article-title":"Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor","volume":"331","author":"King M","year":"1997","unstructured":"King M, Pan YX, Mei J, Chang A, Xu J, Pasternak GW. Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma1 receptor. Eur J Pharmacol. 1997, 331:R5-6. 10.1016\/s0014-2999(97)01064-9","journal-title":"Eur J Pharmacol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.3.1070","article-title":"Sigma1 receptor modulation of opioid analgesia in the mouse","volume":"300","author":"Mei J","year":"2002","unstructured":"Mei J, Pasternak GW. Sigma1 receptor modulation of opioid analgesia in the mouse. J Pharmacol Exp Ther. 2002, 300:1070-4. 10.1124\/jpet.300.3.1070","journal-title":"J Pharmacol Exp Ther"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.24782","article-title":"Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived \u03b1-synuclein","volume":"99","author":"Limegrover CS","year":"2021","unstructured":"Limegrover CS, Yurko R, Izzo NJ, et al.. Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived \u03b1-synuclein. J Neurosci Res. 2021, 99:1161-76. 10.1002\/jnr.24782","journal-title":"J Neurosci Res"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2018.07.003","article-title":"Sigma 1 receptor: a novel therapeutic target in retinal disease","volume":"67","author":"Smith SB","year":"2018","unstructured":"Smith SB, Wang J, Cui X, Mysona BA, Zhao J, Bollinger KE. Sigma 1 receptor: a novel therapeutic target in retinal disease. Prog Retin Eye Res. 2018, 67:130-49. 10.1016\/j.preteyeres.2018.07.003","journal-title":"Prog Retin Eye Res"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.2174\/157015908787386113","article-title":"Pharmacology and therapeutic potential of sigma(1) receptor ligands","volume":"6","author":"Cobos EJ","year":"2008","unstructured":"Cobos EJ, Entrena JM, Nieto FR, Cend\u00e1n CM, Del Pozo E. Pharmacology and therapeutic potential of sigma(1) receptor ligands. Curr Neuropharmacol. 2008, 6:344-66. 10.2174\/157015908787386113","journal-title":"Curr Neuropharmacol"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-50174-1_11","article-title":"Sigma-1 receptor agonists and their clinical implications in neuropsychiatric disorders","volume":"964","author":"Albayrak Y","year":"2017","unstructured":"Albayrak Y, Hashimoto K. Sigma-1 receptor agonists and their clinical implications in neuropsychiatric disorders. Adv Exp Med Biol. 2017, 964:153-61. 10.1007\/978-3-319-50174-1_11","journal-title":"Adv Exp Med Biol"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0697-x","article-title":"The sigma-1 receptor antagonist, S1RA, reduces stroke damage, ameliorates post-stroke neurological deficits and suppresses the overexpression of MMP-9","volume":"55","author":"S\u00e1nchez-Bl\u00e1zquez P","year":"2018","unstructured":"S\u00e1nchez-Bl\u00e1zquez P, Pozo-Rodrig\u00e1lvarez A, Merlos M, Garz\u00f3n J. The sigma-1 receptor antagonist, S1RA, reduces stroke damage, ameliorates post-stroke neurological deficits and suppresses the overexpression of MMP-9. Mol Neurobiol. 2018, 55:4940-51. 10.1007\/s12035-017-0697-x","journal-title":"Mol Neurobiol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00564","article-title":"Trends in sigma-1 receptor research: a 25-year bibliometric analysis","volume":"10","author":"Romero L","year":"2019","unstructured":"Romero L, Portillo-Salido E. Trends in sigma-1 receptor research: a 25-year bibliometric analysis. Front Pharmacol. 2019, 10:564. 10.3389\/fphar.2019.00564","journal-title":"Front Pharmacol"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2012.01335.x","article-title":"Preclinical pharmacology and opioid combinations","volume":"13","author":"Pasternak GW","year":"2012","unstructured":"Pasternak GW. Preclinical pharmacology and opioid combinations. Pain Med. 2012, 13:S4-11. 10.1111\/j.1526-4637.2012.01335.x","journal-title":"Pain Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/123006-the-sigma-enigma-a-narrative-review-of-sigma-receptors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:58Z","timestamp":1707508258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/123006-the-sigma-enigma-a-narrative-review-of-sigma-receptors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,4]]},"references-count":114,"URL":"https:\/\/doi.org\/10.7759\/cureus.35756","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,4]]}}}